Literature DB >> 27267546

Deficiency of cold-inducible ribonucleic acid-binding protein reduces renal injury after ischemia-reperfusion.

Cindy Cen1, Weng-Lang Yang2, Hao-Ting Yen3, Jeffrey M Nicastro1, Gene F Coppa1, Ping Wang4.   

Abstract

BACKGROUND: Renal ischemia-reperfusion injury, commonly caused by major operation and shock, leads to acute kidney injury and is associated with high morbidity and mortality. Cold-inducible ribonucleic acid-binding protein, a cold shock protein, has recently been identified as a damage-associated molecular pattern. We hypothesized that cold-inducible ribonucleic acid-binding protein exacerbates severity of injury in renal ischemia-reperfusion.
METHODS: Renal ischemia was induced in an 8-week-old male C57BL/6 wild-type mice and Cirp(-/-) mice via bilateral clamping of renal pedicles for 30 minutes, followed by reperfusion for 5 or 24 hours and harvest of blood and renal tissue for analysis. Anti-cold-inducible ribonucleic acid-binding protein antibody or non-immunized immunoglobulin G (IgG) was injected intravenously (10 mg/kg body weight) at time of reperfusion.
RESULTS: After renal ischemia-reperfusion, Cirp(-/-) mice demonstrated a reduction of blood urea nitrogen and creatinine of 53% and 60%, respectively, compared with wild-type mice. Serum IL-6 levels were reduced significantly: 70% in Cirp(-/-) mice compared with wild-type mice after renal ischemia-reperfusion. Levels of nitrotyrosine, an oxidatively modified protein marker, and cyclooxygenase-2, an inflammatory mediator, also were significantly decreased in the kidneys of the Cirp(-/-) mice compared with wild-type mice after renal ischemia-reperfusion. Renal caspase-3 activity was decreased in Cirp(-/-) mice compared with wild-type mice after renal ischemia-reperfusion, which corresponded to the reduction of apoptotic cells determined by terminal deoxynucleotidyl transferase dUTP nick-end labeling assay. Injection of neutralizing anti-cold-inducible ribonucleic acid-binding protein antibody into wild-type mice led to an 82% reduction in blood urea nitrogen compared with the vehicle after renal ischemia-reperfusion.
CONCLUSION: Deficiency of cold-inducible ribonucleic acid-binding protein results in less renal injury after renal ischemia-reperfusion by attenuating inflammation and oxidative stress. Furthermore, blockade of cold-inducible ribonucleic acid-binding protein shows a protective effect, indicating cold-inducible ribonucleic acid-binding protein as a target in the treatment of renal ischemia-reperfusion.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27267546      PMCID: PMC4938765          DOI: 10.1016/j.surg.2016.04.014

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  45 in total

Review 1.  Sepsis-associated AKI: epithelial cell dysfunction.

Authors:  David R Emlet; Andrew D Shaw; John A Kellum
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

2.  Role of Cytokines and Chemokines in Renal Ischemia-Reperfusion Injury.

Authors:  Kengo Furuichi; Takashi Wada; Hitoshi Yokoyama; Ken-Ichi Kobayashi
Journal:  Drug News Perspect       Date:  2002-10

3.  Oxidative and nitrosative stress in acute renal ischemia.

Authors:  E Noiri; A Nakao; K Uchida; H Tsukahara; M Ohno; T Fujita; S Brodsky; M S Goligorsky
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

4.  Maladaptive role of IL-6 in ischemic acute renal failure.

Authors:  Mariusz L Kielar; Reji John; Michael Bennett; James A Richardson; John M Shelton; Liying Chen; D Rohan Jeyarajah; Xin J Zhou; Hui Zhou; Brett Chiquett; Glenn T Nagami; Christopher Y Lu
Journal:  J Am Soc Nephrol       Date:  2005-09-28       Impact factor: 10.121

5.  Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney.

Authors:  Shogo Shimizu; Motoaki Saito; Yukako Kinoshita; Fumiya Ohmasa; Fotios Dimitriadis; Kohei Shomori; Atsushi Hayashi; Keisuke Satoh
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

6.  The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats.

Authors:  Hayrettin Ozturk; Ayten Gezici; Hulya Ozturk
Journal:  Hepatol Res       Date:  2005-12-27       Impact factor: 4.288

7.  Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.

Authors:  Thiruma V Arumugam; Sung-Chun Tang; Justin D Lathia; Aiwu Cheng; Mohamed R Mughal; Srinivasulu Chigurupati; Tim Magnus; Sic L Chan; Dong-Gyu Jo; Xin Ouyang; David P Fairlie; Daniel N Granger; Alexander Vortmeyer; Milan Basta; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

8.  The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury.

Authors:  Li Li; Liping Huang; Sun-Sang J Sung; Amy L Vergis; Diane L Rosin; C Edward Rose; Peter I Lobo; Mark D Okusa
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

9.  Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey.

Authors:  Orfeas Liangos; Ron Wald; John W O'Bell; Lorilyn Price; Brian J Pereira; Bertrand L Jaber
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 8.237

10.  Advances in understanding ischemic acute kidney injury.

Authors:  Raj Munshi; Christine Hsu; Jonathan Himmelfarb
Journal:  BMC Med       Date:  2011-02-02       Impact factor: 8.775

View more
  19 in total

1.  C23, an oligopeptide derived from cold-inducible RNA-binding protein, suppresses inflammation and reduces lung injury in neonatal sepsis.

Authors:  Naomi-Liza Denning; Weng-Lang Yang; Laura Hansen; Jose Prince; Ping Wang
Journal:  J Pediatr Surg       Date:  2019-01-04       Impact factor: 2.545

Review 2.  Potential Role of Extracellular CIRP in Alcohol-Induced Alzheimer's Disease.

Authors:  Archna Sharma; Max Brenner; Ping Wang
Journal:  Mol Neurobiol       Date:  2020-08-21       Impact factor: 5.590

3.  Cold-inducible RNA-binding protein-derived peptide C23 attenuates inflammation and tissue injury in a murine model of intestinal ischemia-reperfusion.

Authors:  Joseph T McGinn; Monowar Aziz; Fangming Zhang; Weng-Lang Yang; Jeffrey M Nicastro; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2018-08-25       Impact factor: 3.982

4.  The Protective Effect of A Short Peptide Derived From Cold-Inducible RNA-Binding Protein in Renal Ischemia-Reperfusion Injury.

Authors:  Joseph McGinn; Fangming Zhang; Monowar Aziz; Weng-Lang Yang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Shock       Date:  2018-03       Impact factor: 3.454

5.  Inhibition of the Interaction of TREM-1 and eCIRP Attenuates Inflammation and Improves Survival in Hepatic Ischemia/Reperfusion.

Authors:  Timothy Borjas; Asha Jacob; HaoTing Yen; Vihas Patel; Gene F Coppa; Monowar Aziz; Ping Wang
Journal:  Shock       Date:  2022-02-01       Impact factor: 3.454

6.  A novel eCIRP/TREM-1 pathway inhibitor attenuates acute kidney injury.

Authors:  Sara Siskind; William Royster; Max Brenner; Ping Wang
Journal:  Surgery       Date:  2022-03-12       Impact factor: 4.348

Review 7.  RNA-binding proteins and their role in kidney disease.

Authors:  Michael Ignarski; Roman-Ulrich Müller; Lisa Seufert; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2021-11-03       Impact factor: 42.439

Review 8.  Extracellular CIRP (eCIRP) and inflammation.

Authors:  Monowar Aziz; Max Brenner; Ping Wang
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

9.  A cold-inducible RNA-binding protein (CIRP)-derived peptide attenuates inflammation and organ injury in septic mice.

Authors:  Fangming Zhang; Max Brenner; Weng-Lang Yang; Ping Wang
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

10.  CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia-reperfusion injury.

Authors:  Mingxing Sui; Da Xu; Wenyu Zhao; Hanlan Lu; Rui Chen; Yazhe Duan; Yanhua Li; Youhua Zhu; Lei Zhang; Li Zeng
Journal:  J Cell Mol Med       Date:  2021-06-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.